Compounds derived from quinazolinona tetrahydro -, Tank and parp-1 inhibitors； Preparation Process； Drugs； Pharmaceutical Kit, use in the treatment and / or prevention of cancer, multiple sclerosis, cardiovascular disease, central nervous system injury.

• 收藏
• 分享

专利权人:

MERCK PATENT GMBH

发明人:

LEUTHNER, BIRGITTA,BUCHSTALLER, HANS-PETER,ESDAR, CHRISTINA

申请号：

CL2014002097

公开号：

CL2014002097A1

申请日:

2014.08.07

申请国别(地区):

CL

年份:

2014

代理人:

摘要：

Compounds of the formula I in which U, V and W have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.55 COMPUESTOS ESPECÍFICOS DERIVADOS DE 5,6,7,8-TETRAHIDRO-3H-QUINAZOLINONA, INHIBIDORES DE TANK Y PARP-1； COMPOSICIÓN FARMACÉUTICA； KIT FARMACEUTICO； ÚTILES PARA EL TRATAMIENTO Y/O LA PREVENCION DEL CÁNCER, ESCLEROSIS MÚLTIPLE, ENFERMEDADES CARDIOVASCULARES, LESION DEL SISTEMA NERVIOSO CENTRAL.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/